StockData
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. (SBFM) stock

SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.54−0.06 (-2.31%)

Close on Nov 17, 2026Market cap $9.85MP/E –Yield –

Sunshine Biopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Sunshine Biopharma's pe ratio was 0.0× on Jan 31, 2012.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2012Jan 31, 20120.0×−0.0
2011Dec 30, 20110.0×–

More Sunshine Biopharma figures

See a number that looks wrong?